A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
Titel:
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
Auteur:
Yardley, Denise A. Liggett, William Mainwaring, Mark Castrellon, Aurelio Blakely, Laura Hemphill, Brian Anz III, Bertrand Young, Robyn R. Shastry, Mythili DeBusk, Laura M. Hainsworth, John D. Burris III, Howard A.